This document is a biographical introduction for genetic engineer George Church, detailing his work with the Personal Genome Project, his involvement in the 2013 BRAIN Initiative, and his pioneering work with CRISPR. The text discusses his views on biological engineering versus Artificial Intelligence (AI) and includes quotes regarding the ethical challenges of AI. The document bears a House Oversight stamp, indicating it is part of a production of documents, likely related to the investigation into Jeffrey Epstein's ties to the scientific community (Edge Foundation/Harvard), though Epstein is not explicitly named on this specific page.
This email thread from July 2014 involves Lesley Groff coordinating a call between Jeffrey Epstein and Ed Boyden, following Boyden's update on the Obama BRAIN Initiative and MIT. The thread also includes a forwarded exchange from December 2013 where Groff cancels a lunch meeting with Neil Gershenfeld due to Epstein being sick. Gershenfeld had previously confirmed the lunch at office E15-401 with a joke about future meetings in 'more entertaining venues'.
An email chain from July 2014 where Ed Boyden (MIT) reconnects with Jeffrey Epstein, apologizing for a prior cancellation and citing the success of the Obama BRAIN Initiative as a reason for his busy schedule. Epstein responds with 'definitely' to a request to chat. Included in the thread history are emails from December 2013 involving Neil Gershenfeld confirming a lunch meeting that was subsequently cancelled by Epstein's assistant, Lesley Groff, due to Epstein being ill.
This document is an email chain dated March 14, 2014, in which Lesley Groff informs Jeffrey Epstein that Ed Boyden cannot attend a scheduled dinner. Boyden explains in the original email that he must stay at MIT to work on the 'Obama BRAIN initiative' to meet a deadline and mentions attempting to get a refund for his plane fare. The email is copied to Epstein associates Lyn and Jojo Fontanilla, as well as Neil Gershenfeld and Bella Klein on the original thread.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity